Skip to main content
Clinical Trials/TCTR20180815004
TCTR20180815004
Not yet recruiting
未知

10% Lidocaine spray for pain control during intrauterine device insertion in nulliparous women: A randomized, double-blinded, placebo controlled Trial

Faculty of Medicine Siriraj Hospital0 sites124 target enrollmentMay 15, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
IUD insertion
Sponsor
Faculty of Medicine Siriraj Hospital
Enrollment
124
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 15, 2018
End Date
June 30, 2019
Last Updated
last year
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Woman who required for Copper T IUD insertion
  • Age 18\-45 years
  • New IUD user
  • Body mass index 18\.5 †30 kg/m2
  • Communicable with Thai language

Exclusion Criteria

  • Suspicion of pregnancy
  • Puerperal sepsis/Immediate post\-septic abortion
  • Untreated abnormal uterine bleeding
  • Uterine anomaly/abnormal pathology distorting the uterine cavity
  • Current pelvic inflammatory disease
  • Untreated cervicitis/vaginitis
  • Wilson’s disease
  • Copper allergy
  • known hypersensitivity to local anaesthetics.
  • Analgesic or anxiolytic use within the last 24 h before the procedure

Outcomes

Primary Outcomes

Not specified

Similar Trials